JP2006528144A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528144A5
JP2006528144A5 JP2006520736A JP2006520736A JP2006528144A5 JP 2006528144 A5 JP2006528144 A5 JP 2006528144A5 JP 2006520736 A JP2006520736 A JP 2006520736A JP 2006520736 A JP2006520736 A JP 2006520736A JP 2006528144 A5 JP2006528144 A5 JP 2006528144A5
Authority
JP
Japan
Prior art keywords
pramipexole
active ingredient
tts
tts according
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006520736A
Other languages
English (en)
Japanese (ja)
Other versions
JP4925823B2 (ja
JP2006528144A (ja
Filing date
Publication date
Priority claimed from DE10333393A external-priority patent/DE10333393A1/de
Application filed filed Critical
Publication of JP2006528144A publication Critical patent/JP2006528144A/ja
Publication of JP2006528144A5 publication Critical patent/JP2006528144A5/ja
Application granted granted Critical
Publication of JP4925823B2 publication Critical patent/JP4925823B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006520736A 2003-07-23 2004-07-14 プラミペキソール活性剤を含む経皮治療システム Expired - Fee Related JP4925823B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10333393.2 2003-07-23
DE10333393A DE10333393A1 (de) 2003-07-23 2003-07-23 Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol
PCT/EP2004/007770 WO2005011687A1 (de) 2003-07-23 2004-07-14 Transdermales therapeutisches system mit dem wirkstoff pramipexol

Publications (3)

Publication Number Publication Date
JP2006528144A JP2006528144A (ja) 2006-12-14
JP2006528144A5 true JP2006528144A5 (cg-RX-API-DMAC7.html) 2007-09-06
JP4925823B2 JP4925823B2 (ja) 2012-05-09

Family

ID=34088745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520736A Expired - Fee Related JP4925823B2 (ja) 2003-07-23 2004-07-14 プラミペキソール活性剤を含む経皮治療システム

Country Status (11)

Country Link
US (2) US20060182791A1 (cg-RX-API-DMAC7.html)
EP (1) EP1651215A1 (cg-RX-API-DMAC7.html)
JP (1) JP4925823B2 (cg-RX-API-DMAC7.html)
KR (1) KR20060113638A (cg-RX-API-DMAC7.html)
CN (1) CN100450482C (cg-RX-API-DMAC7.html)
AU (1) AU2004260583B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412240A (cg-RX-API-DMAC7.html)
CA (1) CA2532904A1 (cg-RX-API-DMAC7.html)
DE (1) DE10333393A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005011687A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200600206B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE444750T1 (de) * 2005-08-15 2009-10-15 Univ Virginia Neurorestauration mit r(+) pramipexol
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
CN102160865A (zh) 2006-05-16 2011-08-24 诺普神经科学股份有限公司 R(+)和s(-)普拉克索的组合物以及使用该组合物的方法
WO2008001200A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal composition having enhanced color stability
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
CN101677564A (zh) * 2007-03-14 2010-03-24 诺普神经科学股份有限公司 (6r)-4,5,6,7-四氢-n6-丙基-2,6-苯并噻唑-二胺的改良释放制剂及其使用方法
US8519148B2 (en) 2007-03-14 2013-08-27 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
WO2010010141A1 (en) * 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Pramipexole for treating cardiomyopathy
JP2012500283A (ja) 2008-08-19 2012-01-05 ノップ ニューロサイエンシーズ、インク. (r)−プラミペキソールを使用した組成物並びにその方法
JP5652867B2 (ja) * 2009-11-20 2015-01-14 日東電工株式会社 医療用粘着剤組成物
JP5665116B2 (ja) * 2009-11-20 2015-02-04 日東電工株式会社 貼付剤および貼付製剤
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
DE102012205493A1 (de) 2012-04-03 2013-10-10 Acino Ag Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem
US20140045801A1 (en) * 2012-08-09 2014-02-13 Mylan Inc. Pramipexole transdermal delivery for severe headaches
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9682068B2 (en) * 2013-05-20 2017-06-20 Mylan Inc. Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
RS67279B1 (sr) 2013-07-12 2025-10-31 Areteia Therapeutics Inc Lečenje povišenih nivoa eozinofila i/ili bazofila
EP3033081B1 (en) 2013-08-13 2021-05-12 Knopp Biosciences LLC Compositions and methods for treating chronic urticaria
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
CN103610666A (zh) * 2013-12-11 2014-03-05 中国药科大学 一种盐酸普拉克索透皮贴剂及其制备方法
US10045948B2 (en) 2014-02-27 2018-08-14 Medrx Co., Ltd. Pramipexole-containing transdermal patch for treatment of neurodegenerative disease
US9837244B2 (en) * 2014-12-26 2017-12-05 Industrial Technology Research Insitute Sample holding device for studying light-driven reactions and sample analysis method using the same
CN104510725B (zh) * 2015-01-22 2021-04-27 中国药科大学 一种普拉克索周效透皮贴剂及其制备方法
CN114668747A (zh) * 2016-10-07 2022-06-28 全崴生技股份有限公司 普拉克索经皮贴片系统与用法
CN109999012A (zh) * 2019-03-26 2019-07-12 大道隆达(北京)医药科技发展有限公司 一种普拉克索透皮贴剂及其制备方法
CN111904950B (zh) * 2019-05-07 2023-05-05 上海京新生物医药有限公司 一种普拉克索透皮贴剂
CN117860708A (zh) * 2022-10-11 2024-04-12 姜钦治 含有普拉克索和雷沙吉兰的透皮贴片

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5238944A (en) * 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
WO1996040087A2 (en) * 1995-06-07 1996-12-19 Cygnus, Inc. Pressure sensitive acrylate adhesive composition cross-linked with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group
US6365178B1 (en) * 1996-09-06 2002-04-02 Watson Pharmaceuticals, Inc. Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
US6465004B1 (en) * 1999-06-05 2002-10-15 Noven Pharmaceuticals, Inc. Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
JP2003512414A (ja) * 1999-10-28 2003-04-02 スリーエム イノベイティブ プロパティズ カンパニー 経皮薬物送達装置
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
KR100846642B1 (ko) * 2001-03-07 2008-07-16 히사미쓰 세이야꾸 가부시키가이샤 첩부제
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol

Similar Documents

Publication Publication Date Title
JP4925823B2 (ja) プラミペキソール活性剤を含む経皮治療システム
JP6924298B2 (ja) 経皮薬物送達組成物のためのシリコーン含有アクリルポリマー
JP6895755B2 (ja) 経皮送達システムにおける活性薬剤の放出を調節するための方法
JP4883220B2 (ja) ロチゴチン含有組成物及びその使用並びにこの組成物を含む経皮貼付剤
JP2019525932A5 (cg-RX-API-DMAC7.html)
JP5037831B2 (ja) 凝集力向上及び徐放化の外用貼付剤
JP6556873B2 (ja) 経皮吸収製剤
JP2005528413A5 (cg-RX-API-DMAC7.html)
RU2004131866A (ru) Форма для трансэпикутального введения для лечения синдрома усталых ног
US9056060B2 (en) Non-reactive adhesive useful in transdermal drug delivery system
JP2017515869A (ja) ロチゴチンを含む経皮送達システム
JP2011523650A5 (cg-RX-API-DMAC7.html)
US20070104771A1 (en) Transdermal galantamine delivery system
CN113453676B (zh) 罗替戈汀稳定化方法
CN113710238A (zh) 透皮治疗系统
ES2614466T3 (es) Adhesivos acrílicos sensibles a la presión
US20130281542A1 (en) Selegiline transdermal system
CN102895217A (zh) 长效多奈哌齐经皮吸收贴剂
CN114699391B (zh) 一种罗替高汀透皮吸收贴剂
JP7603143B2 (ja) エスケタミン懸濁tts
JP2015522012A (ja) ロチゴチンを含有した経皮吸収製剤(Transdermalcompositioncomprisingrotigotine)
WO2019167695A1 (ja) ケイ酸カルシウムを含有するアクリル系貼付剤
JP7812050B2 (ja) 貼付剤
JP2014152162A (ja) 貼付剤
MXPA06000779A (en) Transdermaltherapeutic system containing a pramipexol active agent